Modus Therapeutics Holding AB (publ)

DB:99Z Stock Report

Market Cap: €4.0m

Modus Therapeutics Holding Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

John Öhd

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownership4.8%
Management average tenureno data
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO

John Öhd (53 yo)

4.8yrs

Tenure

Dr. John Öhd, M.D., Ph D., serves as Director of Boost Pharma Aps. He has been Chief Executive Officer at Modus Therapeutics AB since June 2020.He serves as Chief Executive Officer Modus Therapeutics Hold...

Board Members

NamePositionTenureCompensationOwnership
Viktor Drvota
Chairman of the Board8.8yrsno datano data
Eddie Weitzberg
Scientific Advisor3.2yrsno datano data
Mats Wahlgren
Scientific Advisor3.2yrsno datano data
Ellen Donnelly
Independent Director4.8yrsno data0.54%
€ 21.7k
Johan Dighed
Directorless than a yearno datano data
Lennart Lindbom
Scientific Advisor3.2yrsno datano data

3.2yrs

Average Tenure

55yo

Average Age

Experienced Board: 99Z's board of directors are considered experienced (3.2 years average tenure).